Fatty liver disease

This week, I was on the hunt for a party dress for my 14-year-old daughter, who was invited to her best friend’s birthday party. I’ve…

E-therapeutics announced positive preclinical toxicology data on ETX-312, its therapy for people with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver…

To me, modern life equals stress. Like everyone else, I’m not immune to the effects of stress on my life. However, as a single mother…

Six months of treatment with lanifibranor, Inventiva’s experimental therapy, reduced abnormalities in liver sinusoidal endothelial cells (LSECs) in people with metabolic dysfunction-associated steatohepatitis (MASH),…

Vacation is all most of us ever want after slogging through spring’s yearning and the early promise of a great summer. We fly to foreign…

Pemvidutide resolved metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease, without worsening liver scarring (fibrosis) for more than half of people…

As I sat down to write this week’s column, my imagination flipped on its silly switch. I couldn’t help but picture a sick cartoon liver…

A committee of the European Medicines Agency (EMA) has granted a positive opinion to Rezdiffra (resmetirom) to treat some people with metabolic dysfunction-associated steatohepatitis (MASH),…

When I started getting sicker from metabolic dysfunction-associated steatohepatitis (MASH), doctors prescribed several medications to manage my symptoms and, hopefully, prevent further damage.

Daily treatment with the diabetes medication dapagliflozin eased disease severity for people with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease,…